
Thursday, May 08, 2025 9:10:05 PM
Amazon case related patent RBR '606 and other related patents '815 and '005 are all tied together and may be vital for arguing the meat of the AntiTrust and Class Action cases - viz. Wi Fi calling feature in smart phones. VPLM's bulls eye is the Wi Fi calling feature integrated into smart phones. It may even touch the MG appeals case in the use of DID database developed by VPLM provided that Mr. Hudnell is replaced by a more aggressive attorney who believes in and UNDERSTANDS VPLM technology and CLAIMS. Stick to claims, not weird precedents.
Don't ignore the Wi Fi calling case in the US court brought by a South Korean professor in which VZ lost $847 million. Probably TMUS lost too!
It is taking a long time to pull various patents, court rulings, etc. for a cogent post.
In a nutshell, there is a good chance for winning the MG case in the appeals court based on past precedents (with a better attorney.) Review all precedents ruled by them. VPLM's current focus is probably to develop a theory of their case to prove charges of monopoly, fees, deception, anticompetitive efforts, etc.
VPLM will come back later to AMZN '606 case, which is also solid in theory of technology used for Wi Fi connections. They do not need to prove patent infringement in the AntiTrust and Class Action cases.
When the summary is done it will be posted. In the meanwhile, key words: Wi Fi calling, DID database.
Recent VPLM News
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 06/17/2025 05:03:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2025 05:00:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/15/2025 04:06:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2025 05:47:41 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 02/20/2025 10:00:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2025 05:25:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/18/2025 05:23:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2025 07:40:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2025 07:31:00 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 02/07/2025 09:58:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/04/2025 06:59:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/27/2025 08:53:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2025 06:24:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/14/2025 05:27:46 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/26/2024 07:00:44 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 10/25/2024 08:55:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/25/2024 08:15:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2024 06:23:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/21/2024 01:20:09 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/16/2024 03:50:52 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/15/2024 06:54:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/23/2024 09:48:49 PM
VAYK Project 100% Revenue Growth Before Half Year Report • VAYK • Jul 14, 2025 8:58 AM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM